Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2007-11-06
2007-11-06
Nickol, Gary B. (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C530S387300
Reexamination Certificate
active
10015967
ABSTRACT:
The present invention is directed to novel polypeptides having structural homology to IL-8 and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treatment and diagnosis of inflammatory diseases.
REFERENCES:
patent: 4736866 (1988-04-01), Leder et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5364934 (1994-11-01), Drayna et al.
patent: 5536637 (1996-07-01), Jacobs
patent: 2005/0100544 (2005-05-01), Eaton et al.
patent: 2006/0019307 (2006-01-01), Eaton et al.
patent: 2006/0183169 (2006-08-01), Eaton et al.
patent: 2006/0210991 (2006-09-01), Eaton et al.
patent: 1111046 (2001-06-01), None
patent: WO94/10308 (1994-05-01), None
patent: WO97/33551 (1997-09-01), None
patent: WO98/33926 (1998-08-01), None
patent: WO98/45712 (1998-10-01), None
patent: WO99/60160 (1999-11-01), None
patent: WO99/63088 (1999-12-01), None
patent: WO 00/00610 (2000-01-01), None
patent: WO 00/14226 (2000-03-01), None
patent: WO 00/55375 (2000-09-01), None
patent: WO 00/73454 (2000-12-01), None
patent: WO 01/16318 (2001-03-01), None
P.A. Haynes et al. Proteome analysis: biological assay or data archive? 1998. Electrophoresis, 19: 1862-1871.
Abel and Maniatis., “Action of Leucine Zippers.”Nature. 341:24-25 (Sep. 1989).
Anderson et al., “Molecular and Biological Characterization of Human 4-1BB and Its Ligand.”European Journal of Immunology. 24(9):2219-2227 (Sep. 1994).
Altschul and Gish, “Local Alignment Statistics”Methods in Enzymology266:460-480 (1996).
Altschul et al., “Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs.”Nucleic Acids Research. 25(17):3389-3402 (1997).
Anderson, W.F., “Human Gene Therapy.”Science. 256(5058):808-813 (May 8, 1992).
Atta-ur-Rahman et al., “Interleukin-8: An Autocrine Inflammatory Mediator.”Curr. Pharm. Design. 5 (4) :241-253 (1999).
Baggiolini et al., “Human Chemokines: An Update.”Annu. Rev. Immunol. 15:675-705 (1997).
Banchereau and Steinman., “Dendritic Cells and the Control of Immunity.”Nature. 392:245-252 (Mar. 1998).
Bazan et al., “A New Class of Membrane-Bound Chemokine With a CX(3) C Motif.”Nature. 385:640-644 (Feb. 1997).
Beal and Dervan, “Second Structural Motif for Recognition of DNA by Oligonucleotide-Directed Triple-Helix Formation”Science251:1360-1363 (1991).
Bradley, “Production and Analysis of Chimaeric Mice”Teratocarcinomas and Embryonic Stem Cells: A Practical Approach, E. J. Robertson, ed., IRL, Oxford, Chapter 5, pp. 113-151 (1987).
Broxmeyer et al., “Myelopoietic Enhancing Effects of Murine Macrophage Inflammatory Proteins 1 and 2 on Colony Formation In Vitro by Murine and Human Bone Marrow Granulocyte/Macrophage Progenitor Cells.”J. Exp. Medicine. 170:1583-1594 (1989).
Cao et al., “gro-β, A -C-X-C- Chemokine, Is An Angiogenesis Inhibitor That Suppresses the Growth of Lewis Lung Carcinoma in Mice.”J. Exp. Medicine. 182:2069-2077 (Dec. 1995).
Cao et al., “Molecular Cloning and Characterization of a Novel CXC Chemokine Macrophage Inflammatory Protein-2γ Chemoattractant for Human Neutrophils and Dendritic Cells.”J. Immunol. 165:2588-2595 (2000).
Carter et al., “Improved Oligonucleotide Site-Directed Mutagenesis Using M13 Vectors”Nucl. Acids Res. 13(12):4431-4443 (Jun. 25, 1985).
Chambers and Allison., “Co-Stimulation in T Cell Responses.”Current Opinion in Immunology. 9(3):396-404 (Jun. 1997).
Chevray and Nathans, “Protein Interaction Cloning in Yeast: Identification of Mammalian Proteins That React With the Leucine Zipper of Jun”Proc. Natl. Acad. Sci. USA89:5789-5793 (Jul. 1992).
Chien et al., “The Two-Hybrid System: A Method to Identify and Clone Genes for Proteins that Interact with a Protein of Interest.”Proc. Natl. Acad. Sci. USA88:9578-9582 (1991).
Chothia, “The Nature of the Accessible and Buried Surfaces in Proteins”Journal Mol. Biol. 105:1-14 (1976).
Cocchi et al., “Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells.”Science. 270:1811-1815 (Dec. 1995).
Cooney et al., “Site-Specific Oligonucleotide Binding Represses Transcription of the Human c-myc Gene in Vitro”Science241:456-459 (Jul. 22, 1988).
Creighton, Thomas E.Proteins: Structures and Molecular Properties, N.Y. :W.H. Freeman & Co. (1983).
Cunningham and Wells, “High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis”Science244:1081-1085 (1989).
De Smet et al., “The Activation of Human Gene MAGE-1 in Tumor Cells is Correlated with Genome-Wide Demethylation.”Proc. Natl. Acad. Sci. USA93 (14):7149-7153 (Jul. 9, 1996).
Domingues et al., “Sustained Performance of Knowledge-Based Potentials in Fold Recognition.”Proteins. 3:112-120 (1999).
Dzau et al., “Gene Therapy for Cardiovascular Disease.”Trends in Biotechnology. 11:205-210 (1993).
Evans et al., “Isolation of Monoclonal Antibodies Specific for Human c-myc Proto-Oncogene Product”Molecular&Cellular Biology5:3610-3616 (1985).
Field et al., “Purification of a RAS-Responsive Adenylyl Cyclase Complex from Saccharomyces cerevisiae by Use of an Epitope Addition Method”Molecular&Cellular Biology8:2159-2165 (1988).
Fields and Songs., “A Novel Genetic System to Detect Protein-Protein Interactions.”Nature. 340:245-246 (1989).
Finn and Lotze., “Introduction: Third Keystone Symposium on Cellular Immunology and the Immunotherapy of Cancer.”Journal of Immunotherapy. 21(2):114-118 (Mar. 1998).
Gale and McColl., “Chemokines: Extracellular Messengers For All Occasions?”BioEssays. 21:17-28 (1999).
Hellstrom and Hellstrom., “T Cell Immunity to Tumor Antigens.”Critical Reviews in Immunology. 18(1-2):1-6 (1998).
Henikoff, S. and J. G. Henikoff., “Amino Acid Substitution Matrices from Protein Blocks.”Proc. Natl. Acad. Sci. USA89:10915-10919 (1992).
Hopp et al., “A Short Polypeptide Marker Sequence Useful for Recombinant Protein Identification and Purification”Bio/Technology6:1204-1210 (1988).
Hoppe et al., “A Parallel Three Stranded Alpha-Helical Bundle at the Nucleation Site of Collagen Triple-Helix Formation.”FEBS Letters. (abstract) 344(2-3):191-5 (1994).
Jenkins, M., “The Ups and Downs of T Cell Costimulation.”Immunity. 1(6):443-446 (Sep. 1994).
June et al., “the B7 and CD28 Receptor Families.”Immunology Today. 15(7):321-331 (Jul. 1994).
Kelner, G.S., “Lymphotactin: A Cytokine That Represents a New Class of Chemokine.”Science. 266:1395-1399 (Nov. 1994).
Kennedy et al., “Molecular Cloning and Functional Characterization of Human Lymphotactin.”J. Immunol. 155:203-209 (1995).
Klein et al., “Selection for Genes Encoding Secreted Proteins and Receptors”Proc. Natl. Acad. Sci. USA93(14):7108-7113 (1996).
Kurdowska et al., “Anti-Interleukin 8 Autoantibody: Interleukin 8 Complexes in the Acute Respiratory Distress Syndrome.”Amer. J. Resp. Crit. Care Med. 163(2):463-468 (2001).
Kwon et al., “Manipulation of T Cell Costimulatory and Inhibitory Signals for Immunotherapy of Prostate Cancer.”Proc. Natl. Acad. Sci. USA94(15):8099-8103 (Jul. 22, 1997).
Lakso et al., “Targeted Oncogene Activation by Site-Specific Recombination in Transgenic Mice.”Proc. Natl. Acad. Sci. USA. 89:6232-6236 (Jul. 1992).
Lan
Eaton Dan L.
French Dorothy
Grimaldi J. Christopher
Hillan Kenneth J.
Pisabaro Maria Teresa
Genentech Inc.
Jiang Dong
Nickol Gary B.
Sidley Austin LLP
LandOfFree
Interleukin-8 homologous polypeptides and therapeutic uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin-8 homologous polypeptides and therapeutic uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-8 homologous polypeptides and therapeutic uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3803689